# Vaylar Guidance

[Weekly Email 9/02/23](https://mygainwell-my.sharepoint.com/:w:/g/personal/christopher_nguyen_gainwelltechnologies_com/EbKyADESU_ZFq34v8LclCwoBT3LoDtroZEYJuNBbRJ7YUQ?e=eZmqEt){:target="_blank" rel="noopener"}

**Lexicomp**: ***Major depressive disorder (unipolar) ==(adjunctive therapy with antidepressant)==:*** Oral: Initial: 1.5 mg once daily, may increase based on response and tolerability to 3 mg once daily on day 15. Maximum dose: 3 mg/day, however, some experts recommend increasing to 4.5 mg/day based on response and tolerability

â€¢	For ==decisioning Vraylar for depression, 2 preferred antipsychotics must be used prior==. The preferred options with the specific diagnosis are aripiprazole and quetiapine ER. 

## FDA Approved Alternatives

***FDA Approved Alternatives***: Aripiprazole, Quetiapine ER

***Off-label***: Quetiapine IR, Geodon, Latuda, Olanzapine, Risperidone, Ziprasidone

### Possible denial language:

Coverage is provided when the member has a history of at least 30 days of therapy with two preferred (medication covered by the Plan) medications, which include but are not limited to: Aripiprazole or Quetiapine ER.
